학술논문
Assessment of early response biomarkers in relation to long-term survival in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy plus bevacizumab: Results from the Phase II PROMIX trial
Document Type
Article
Author
Source
In: International Journal of Cancer . (International Journal of Cancer, 1 February 2018, 142(3):618-628)
Subject
Language
English
ISSN
10970215
00207136
00207136